-
Dosimetric calibration of an anatomically specific ultra-high dose rate electron irradiation platform for preclinical FLASH radiobiology experiments
Authors:
Jinghui Wang,
Stavros Melemenidis,
Rakesh Manjappa,
Vignesh Viswanathan,
Ramish M. Ashraf,
Karen Levy,
Lawrie Skinner,
Luis A. Soto,
Stephanie Chow,
Brianna Lau,
Ryan B. Ko,
Edward E. Graves,
Amy S. Yu,
Karl K. Bush,
Murat Surucu,
Erinn B. Rankin,
Billy W. Loo Jr,
Emil Schüler,
Peter G. Maxim
Abstract:
We characterized the dosimetric properties of a clinical linear accelerator configured to deliver ultra-high dose rate (UHDR) irradiation to mice and cell-culture FLASH radiobiology experiments. UHDR electron beams were controlled by a microcontroller and relay interfaced with the respiratory gating system. We produced beam collimators with indexed stereotactic mouse positioning devices to provide…
▽ More
We characterized the dosimetric properties of a clinical linear accelerator configured to deliver ultra-high dose rate (UHDR) irradiation to mice and cell-culture FLASH radiobiology experiments. UHDR electron beams were controlled by a microcontroller and relay interfaced with the respiratory gating system. We produced beam collimators with indexed stereotactic mouse positioning devices to provide anatomically specific preclinical treatments. Treatment delivery was monitored directly with an ionization chamber, and charge measurements were correlated with radiochromic film at the entry surface of the mice. The setup for conventional (CONV) dose rate irradiation was similar but the source-to-surface distance was longer. Monte Carlo simulations and film dosimetry were used to characterize beam properties and dose distributions. The mean electron beam energies before the flattening filter were 18.8 MeV (UHDR) and 17.7 MeV (CONV), with corresponding values at the mouse surface of 17.2 MeV and 16.2 MeV. The charges measured with an external ion chamber were linearly correlated with the mouse entrance dose. Use of relay gating for pulse control initially led to a delivery failure rate of 20% ($+/-$ 1 pulse); adjustments to account for the linac latency improved this rate to <1/20. Beam field sizes for two anatomically specific mouse collimators (4x4 $cm^2$ for whole-abdomen and 1.5x1.5 $cm^2$ for unilateral lung irradiation) were accurate within <5% and had low radiation leakage (<4%). Normalizing the dose at the center of the mouse (~0.75 cm depth) produced UHDR and CONV doses to the irradiated volumes with >95% agreement. We successfully configured a clinical linear accelerator for increased output and developed a robust preclinical platform for anatomically specific irradiation, with highly accurate and precise temporal and spatial dose delivery, for both CONV and UHDR applications.
△ Less
Submitted 17 December, 2023;
originally announced December 2023.
-
Multi-Institutional Audit of FLASH and Conventional Dosimetry with a 3D-Printed Anatomically Realistic Mouse Phantom
Authors:
M Ramish Ashraf,
Stavros Melemenidis,
Kevin Liu,
Veljko Grilj,
Jeannette Jansen,
Brett Velasquez,
Luke Connell,
Joseph B Schulz,
Claude Bailat,
Aaron Libed,
Rakesh Manjappa,
Suparna Dutt,
Luis Soto,
Brianna Lau,
Aaron Garza,
William Larsen,
Lawrie Skinner,
Amy S Yu,
Murat Surucu,
Edward E Graves,
Peter G Maxim,
Stephen F. Kry,
Marie-Catherine Vozenin,
Emil Schüler,
Billy W Loo Jr
Abstract:
We conducted a multi-institutional audit of dosimetric variability between FLASH and conventional dose rate (CONV) electron irradiations by using an anatomically realistic 3D-printed mouse phantom. A CT scan of a live mouse was used to create a 3D model of bony anatomy, lungs, and soft tissue. A dual-nozzle 3D printer was used to print the mouse phantom using acrylonitrile butadiene styrene (…
▽ More
We conducted a multi-institutional audit of dosimetric variability between FLASH and conventional dose rate (CONV) electron irradiations by using an anatomically realistic 3D-printed mouse phantom. A CT scan of a live mouse was used to create a 3D model of bony anatomy, lungs, and soft tissue. A dual-nozzle 3D printer was used to print the mouse phantom using acrylonitrile butadiene styrene ($~1.02 g/cm^3$) and polylactic acid ($~1.24 g/cm^3$) simultaneously to simulate soft tissue and bone densities, respectively. The lungs were printed separately using lightweight polylactic acid ($~0.64 g/cm^3$). Hounsfield units (HU) and densities were compared with the reference CT scan of the live mouse. Print-to-print reproducibility of the phantom was assessed. Three institutions were each provided a phantom, and each institution performed two replicates of irradiations at selected mouse anatomic regions. The average dose difference between FLASH and CONV dose distributions and deviation from the prescribed dose were measured with radiochromic film. Compared to the reference CT scan, CT scans of the phantom demonstrated mass density differences of $0.10 g/cm^3$ for bone, $0.12 g/cm^3$ for lung, and $0.03 g/cm^3$ for soft tissue regions. Between phantoms, the difference in HU for soft tissue and bone was <10 HU from print to print. Lung exhibited the most variation (54 HU) but minimally affected dose distribution (<0.5% dose differences between phantoms). The mean difference between FLASH and CONV from the first replicate to the second decreased from 4.3% to 1.2%, and the mean difference from the prescribed dose decreased from 3.6% to 2.5% for CONV and 6.4% to 2.7% for FLASH. The framework presented here is promising for credentialing of multi-institutional studies of FLASH preclinical research to maximize the reproducibility of biological findings.
△ Less
Submitted 28 September, 2023;
originally announced September 2023.
-
Transformative Technology for FLASH Radiation Therapy: A Snowmass 2021 White Paper
Authors:
Salime Boucher,
Eric Esarey,
Cameron Geddes,
Carol Johnstone,
Sergey Kutsaev,
Billy W. Loo Jr,
Francois Méot,
Brahim Mustapha,
Kei Nakamura,
Emilio Nanni,
Lieselotte Obst-Huebl,
Stephen E. Sampayan,
Carl Schroeder,
Reinhard Schulte,
Ke Sheng,
Antoine Snijders,
Emma Snively,
Sami G. Tantawi,
Jeroen van Tilborg
Abstract:
Conventional cancer therapies include surgery, radiation therapy, chemotherapy, and, more recently, immunotherapy. These modalities are often combined to improve the therapeutic index. The general concept of radiation therapy is to increase the therapeutic index by creating a physical dose differential between tumors and normal tissues through precision dose targeting, image guidance, and high rad…
▽ More
Conventional cancer therapies include surgery, radiation therapy, chemotherapy, and, more recently, immunotherapy. These modalities are often combined to improve the therapeutic index. The general concept of radiation therapy is to increase the therapeutic index by creating a physical dose differential between tumors and normal tissues through precision dose targeting, image guidance, and high radiation beams that deliver radiation dose with high conformality, e.g., protons and ions. However, treatment and cure are still limited by normal tissue radiation toxicity, with many patients experiencing acute and long-term side effects. Recently, however, a fundamentally different paradigm for increasing the therapeutic index of radiation therapy has emerged, supported by preclinical research, and based on the FLASH radiation effect. FLASH radiation therapy (FLASH-RT) is an ultra-high dose-rate delivery of a therapeutic radiation dose within a fraction of a second. Experimental studies have shown that normal tissues seem to be universally spared at these high dose rates, whereas tumors are not. The dose delivery conditions are not yet fully characterized. Still, it is currently estimated that large doses of 10 Gy or more delivered in 200 ms or less produce normal tissue sparing effects yet effectively kill tumor cells. There is a great opportunity, but also many technical challenges, for the accelerator community to create the required dose rates with novel and compact accelerators to ensure the safe delivery of FLASH radiation beams.
△ Less
Submitted 21 March, 2022;
originally announced March 2022.
-
Towards a Computed Collateral Circulation Score in Ischemic Stroke
Authors:
Marta Kersten-Oertel,
Ali Alamer,
Vladimir Fonov,
Benjamin W. Y. Lo,
Donatella Tampieri,
D. Louis Collins
Abstract:
Stroke is the second leading cause of disability worldwide. In order to minimize disability, the goal of stroke treatment is to preserve tissue in the area where blood supply is decreased but sufficient to stave off cell death. Thrombectomy has been shown to offer fast and efficient reperfusion with high recanalization rates. However, due to the inherent risks of thrombectomy, indications includin…
▽ More
Stroke is the second leading cause of disability worldwide. In order to minimize disability, the goal of stroke treatment is to preserve tissue in the area where blood supply is decreased but sufficient to stave off cell death. Thrombectomy has been shown to offer fast and efficient reperfusion with high recanalization rates. However, due to the inherent risks of thrombectomy, indications including evidence of good collateral circulation should be present. Currently, methods for evaluating collateral circulation are limited. In this work, we present an automated technique to compute a collateral circulation score based on differences seen in mean intensities between left and right cerebral hemispheres in 4D angiography images. In this preliminary study, we analyzed scans of 28 subjects: 4 with normal collateral circulation, 7 with good, 10 with intermediate, and 7 with poor collateral circulation, (based on radiologist score) and found a good correlation between the computed score and radiologist score (r2 = 0.71) and good separation between good and intermediate/poor groups. This work shows promise as the first step in building an automated collateral circulation score.
△ Less
Submitted 20 January, 2020;
originally announced January 2020.
-
Deep segmentation networks predict survival of non-small cell lung cancer
Authors:
Stephen Baek,
Yusen He,
Bryan G. Allen,
John M. Buatti,
Brian J. Smith,
Ling Tong,
Zhiyu Sun,
Jia Wu,
Maximilian Diehn,
Billy W. Loo,
Kristin A. Plichta,
Steven N. Seyedin,
Maggie Gannon,
Katherine R. Cabel,
Yusung Kim,
Xiaodong Wu
Abstract:
Non-small-cell lung cancer (NSCLC) represents approximately 80-85% of lung cancer diagnoses and is the leading cause of cancer-related death worldwide. Recent studies indicate that image-based radiomics features from positron emission tomography-computed tomography (PET/CT) images have predictive power on NSCLC outcomes. To this end, easily calculated functional features such as the maximum and th…
▽ More
Non-small-cell lung cancer (NSCLC) represents approximately 80-85% of lung cancer diagnoses and is the leading cause of cancer-related death worldwide. Recent studies indicate that image-based radiomics features from positron emission tomography-computed tomography (PET/CT) images have predictive power on NSCLC outcomes. To this end, easily calculated functional features such as the maximum and the mean of standard uptake value (SUV) and total lesion glycolysis (TLG) are most commonly used for NSCLC prognostication, but their prognostic value remains controversial. Meanwhile, convolutional neural networks (CNN) are rapidly emerging as a new premise for cancer image analysis, with significantly enhanced predictive power compared to other hand-crafted radiomics features. Here we show that CNN trained to perform the tumor segmentation task, with no other information than physician contours, identify a rich set of survival-related image features with remarkable prognostic value. In a retrospective study on 96 NSCLC patients before stereotactic-body radiotherapy (SBRT), we found that the CNN segmentation algorithm (U-Net) trained for tumor segmentation in PET/CT images, contained features having strong correlation with 2- and 5-year overall and disease-specific survivals. The U-net algorithm has not seen any other clinical information (e.g. survival, age, smoking history) than the images and the corresponding tumor contours provided by physicians. Furthermore, through visualization of the U-Net, we also found convincing evidence that the regions of progression appear to match with the regions where the U-Net features identified patterns that predicted higher likelihood of death. We anticipate our findings will be a starting point for more sophisticated non-intrusive patient specific cancer prognosis determination.
△ Less
Submitted 8 November, 2019; v1 submitted 26 March, 2019;
originally announced March 2019.